Fig. 3From: Recombinant pharmaceuticals from microbial cells: a 2015 updateAmount of marketed recombinant proteins (expressed in percentages) applied to each therapeutic area. Coloured in pink, other therapeutic areas (<5 % each) include diseases related to cardiology, central nervous system, ophthalmology and dermatology among othersBack to article page